Search

Your search keyword '"Iron deposition"' showing total 959 results

Search Constraints

Start Over You searched for: Descriptor "Iron deposition" Remove constraint Descriptor: "Iron deposition"
959 results on '"Iron deposition"'

Search Results

201. FA2H Mutations in a Young Adult Presenting as an Isolated Cognitive Impairment Syndrome

202. Treatment of iron overload syndrome: a general review

203. Age-Related Iron Deposition in the Deep Brain Structures of Normal Subjects: A Post-Mortem 7.0-Tesla Magnetic Resonance Study

204. Electrode-electrolyte interactions in choline chloride ethylene glycol based solvents and their effect on the electrodeposition of iron

205. Susceptibility-weighted MR imaging (SWI) of basal ganglia iron deposition in the early and advanced stages of Parkinson's disease

206. Perivascular spaces in the centrum semiovale at the beginning of the 8th decade of life: effect on cognition and associations with mineral deposition

207. Sclerosing angiomatoid nodular transformation of the spleen: A case report of thrombocytopenia and a hypervascular splenic mass

208. Age-related microstructural and physiological changes in normal brain measured by MRI γ-metrics derived from anomalous diffusion signal representation

209. Quantitative MRI of Diffuse Liver Disease: Current Applications and Future Directions

210. Evaluation of iron deposition in brain basal ganglia of patients with Parkinson's disease using quantitative susceptibility mapping

211. Evaluation of iron overload in nigrosome 1 via quantitative susceptibility mapping as a progression biomarker in prodromal stages of synucleinopathies.

212. Reproducible detection of nigral iron deposition in 2 Parkinson's disease cohorts

213. Alpha-lipoic acid attenuates iron-overload-induced structural changes in the liver of the laboratory mouse (Mus musculus)

214. Nigral iron deposition in common tremor disorders

215. Erastin‑induced ferroptosis causes physiological and pathological changes in healthy tissues of mice

216. Voxel-based quantitative susceptibility mapping revealed increased cerebral iron over the whole brain in chronic migraine

217. Iron Metabolism Disorders for Cognitive Dysfunction After Mild Traumatic Brain Injury

218. Ictal hypoperfusion and iron deposition in the symptomatogenic zone of epilepsia partialis continua - A case report

219. Susceptibility-weighted Imaging for Renal Iron Overload Assessment: A Pilot Study

220. Iron Protein Succinylate in the Management of Iron Deficiency Anemia: A Comparative Study with Ferrous Sulphate at Low and High Therapeutic Doses

221. Ferroptosis and Cancer Immunotherapy.

222. Effect of corticosubcortical iron deposition on dysfunction in CADASIL is mediated by white matter microstructural damage.

223. Metabolic Insights into Iron Deposition in Relapsing-Remitting Multiple Sclerosis via 7 T Magnetic Resonance Spectroscopic Imaging.

224. Blood circulating microparticle species in relapsing–remitting and secondary progressive multiple sclerosis. A case–control, cross sectional study with conventional MRI and advanced iron content imaging outcomes.

225. Increased brain iron deposition is a risk factor for brain atrophy in patients with haemodialysis: a combined study of quantitative susceptibility mapping and whole brain volume analysis.

226. Characterizing brain iron deposition in subcortical ischemic vascular dementia using susceptibility-weighted imaging: An in vivo MR study.

227. Efficient imaging of midbrain nuclei using inverse double-echo steady-state acquisition.

228. Iron deposition in the gray matter in patients with relapse-remitting multiple sclerosis: A longitudinal study using three-dimensional (3D)-enhanced T2*-weighted angiography (ESWAN).

229. Hydrogen evolution on plasma carburised nickel and effect of iron deposition from the electrolyte in alkaline water electrolysis.

230. Introducing a new histologic scoring system for iron deposition in liver of thalassemic patients, compared with atomic absorption spectrometry.

231. Associations between changes in ferritin levels and susceptibility-weighted imaging filtered phase in patients with relapsing–remitting multiple sclerosis over 24 weeks of therapy with subcutaneous interferon beta-1a three times weekly.

232. Quantitative measurement of brain iron deposition in patients with haemodialysis using susceptibility mapping.

233. Putaminal hypointensity on T2*-weighted MR imaging is the most practically useful sign in diagnosing multiple system atrophy: A preliminary study.

234. Atmospheric iron deposition in the northwestern Pacific Ocean and its adjacent marginal seas: The importance of coal burning.

235. Characterization of age-related microstructural changes in locus coeruleus and substantia nigra pars compacta.

236. MR PHASE AND SUSCEPTIBILITY-WEIGHTED IMAGING OF IRON DEPOSITION IN MULTIPLE SCLEROSIS AND RADIATION-TREATED BRAIN TUMORS

237. Mitochondrial Membrane Protein-associated Neurodegeneration: Two Adult Cases with Different Clinical Presentation

238. Increased Brain Iron Detection by Voxel-Based Quantitative Susceptibility Mapping in Type 2 Diabetes Mellitus Patients With an Executive Function Decline

241. Association of Brain Iron Overload With Brain Edema and Brain Atrophy After Intracerebral Hemorrhage

242. Response by Rodemerk et al to Letter Regarding Article, 'Pathophysiology of Intracranial Aneurysms: COX-2 Expression, Iron Deposition in Aneurysm Wall, and Correlation With Magnetic Resonance Imaging'

243. Dysfunction of the Glymphatic System Might Be Related to Iron Deposition in the Normal Aging Brain

244. The role of iron present in water environment in degradation of polyamide membranes by free chlorine.

Catalog

Books, media, physical & digital resources